Intercure is engaged in the medical cannabis sector. Co. has two direct subsidiaries, Canndoc Ltd. (Canndoc) and Cannolam Ltd. (Cannolam). Canndoc's operations are focused on the production (including the breeding, cultivating, importing and processing), manufacturing, exporting and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use. Cannolam's operations are focused on establishing and operating dedicated pharmacies for the distribution of pharmaceutical-grade cannabis under the brand name Givol, including a Cookies-branded location. The INCR stock yearly return is shown above.
The yearly return on the INCR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the INCR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|